loader image
Monday, December 22, 2025
78.3 F
McAllen
- Advertisement -

COVID Vaccine Preprint Study Prompts Twitter Outrage

Translate to Spanish or other 102 languages!

Image for illustration for Illustration purposes.

Medscape

- Advertisement -

A preprint study finding that the Pfizer-BioNTech mRNA COVID vaccine is associated with an increased risk for cardiac adverse events in teenage boys has elicited a firestorm on Twitter. 

Although some people issued thoughtful critiques, others lobbed insults against the authors, and still others accused them of either being anti-vaccine or stoking the fires of the vaccine skeptic movement.

For the complete story, click on the following link: https://www.medscape.com/viewarticle/958778?uac=209076CT&faf=1&sso=true&impID=3641968&src=mkm_covid_update_210915_MSCPEDIT

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS’ “South Texas Healthy Living” Dedicates Episode to Colon Health, Dec. 28th

It may come as a surprise, but colon health is a vital part of your overall well-being; it profoundly impacts nearly every system in the body.

6 Depression Symptoms in Midlife Linked to Almost 50% Higher Dementia Risk

In 2021, about 57 million people globally were living with dementia — an umbrella term for neurological conditions that impact a person’s cognitive skills and memory, such as Alzheimer’s disease and vascular dementia

From Patient to Hero: Isaac Garza Delivers 2,089 Smiles This Holiday Season

Mega Doctor News For Isaac Garza, it’s better to give than to receive during the...

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.
- Advertisement -
×